Preliminary Characterization of NP339, a Novel Polyarginine Peptide with Broad Antifungal Activity

Fungi cause disease in nearly one billion individuals worldwide. Only three classes of antifungal agents are currently available in mainstream clinical use. Emerging and drug-resistant fungi, toxicity, and drug-drug interactions compromise their efficacy and applicability. Consequently, new and impr...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Antimicrob Agents Chemother
Hlavní autoři: Duncan, Vanessa, Smith, Daniel, Simpson, Laura, Lovie, Emma, Katvars, Laura, Berge, Leon, Robertson, Jennifer, Smith, Shane, Munro, Carol, Mercer, Derry, O’Neil, Deborah
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology 2021
Témata:
Experimental Therapeutics
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8284473/
https://ncbi.nlm.nih.gov/pubmed/34031048
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02345-20
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky